# Trialtus Bioscience, LLC — Form D

Trialtus Bioscience, LLC of BIRMINGHAM, AL, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-16. The offering totals $2.0M, of which $1.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-04-16
- Form: D
- Accession: 0001771358-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.6M
- Remaining: $425K
- Minimum investment: $25K
- Investors: 13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-337489

## Issuer

- Name: Trialtus Bioscience, LLC
- CIK: 0001771358
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1500 1ST AVENUE NORTH UNIT 92, BIRMINGHAM, AL, 35203
- Phone: 205-601-6557

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Robert Shufflebarger | Related Person | Birmingham, AL |
| Robert Shufflebarger | Executive Officer | Birmingham, AL |

## More

- [CIK 1771358 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1771358&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001771358-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.